Testosterone as a Biomarker of Adverse Clinical Outcomes in SARS-CoV-2 Pneumonia.

Lorenzo Marinelli Guglielmo BeccutiMarco ZavattaroSerena CagninaIacopo GesmundoChiara BonaChiara LopezSilvia ScabiniFrancesca CantaSimone Mornese PinnaTommaso LupiaCataldo Di BisceglieFederico PonzettoFabio SettanniFrancesco Giuseppe De RosaEzio GhigoGiovanna Motta

Published in: Biomedicines (2022)

Both TT and cFT levels are associated with adverse clinical outcomes in men admitted with SARS-CoV-2 pneumonia. As TT, cFT and InhB levels increase before discharge, short-term functional recovery of steroidogenesis and an indirect improvement of spermatozoa functional status could be hypothesized.

Keyphrases

sars cov
respiratory syndrome coronavirus
middle aged
adverse drug
replacement therapy
coronavirus disease